{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Gary Erik Aspnes", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ga_ln:aspnes-1"}]}

Home › 2021 › Pfizer › Gary Erik Aspnes

Gary Erik Aspnes — 1 Patent in 2021

Pfizer: 1 patents #97 of 325Top 30%

Overall (2021): #453,018 of 548,734Top 85%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10934279	GLP-1 receptor agonists and uses thereof	Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more	2021-03-02	$1,471,575,000

Gary Erik Aspnes — 1 Patent in 2021

Issued Patents 2021

Patent Widget